97 POSTER Analysis of EGFR and KRAS mutations in circulating tumor DNA (cTDNA) from plasma of NSCLC patients in phase 2 trials of XL647
F. Schimmoller, N.A. Rizvi, V.S. Vysotskaia, R.P. Funke, S. Dixon, R.E. BullerVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72029-9
File:
PDF, 60 KB
english, 2008